Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Nov;24(11 Suppl):V9-11.
doi: 10.1002/clc.4960241704.

INVEST substudies: design and patient characteristics

M Keltai  1 , J A Johnson, P R Kowey, L D Ried, M Tueth
Affiliations

INVEST substudies: design and patient characteristics

M Keltai et al. Clin Cardiol. 2001 Nov.

Abstract

The INternational VErapamil SR/trandolapril STudy (INVEST) will provide a large database of information. Proposed substudies for analysis include ambulatory blood pressure monitoring (ABPM), depression, genotyping, atrial fibrillation, electrocardiogram (ECG), echocardiography, renal dysfunction, diabetes, and cardiac care cost estimate. This paper reviews the design and status of several of the INVEST substudies. The ABPM substudy will obtain objective blood pressure recordings during daily life masked to both the patient and the investigator. Ambulatory blood pressure monitoring is an especially useful technology because of the role of nocturnal hypertension and circadian blood pressure irregularities in the development of hypertensive disease. The depression substudy, which enrolled 2,393 patients in the United States, will report quality-of-life (QOL) data, including information regarding energy and fatigue. The genotyping substudy will provide genomic DNA samples from approximately 15,000 patients in the United States, including Puerto Rico. Many candidate genes will be examined for polymorphisms that may predict outcomes and/or responses to various treatments.

PubMed Disclaimer

References

    1. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413–2446 - PubMed
    1. Verdecchia P., Porcellati C., Schillaci G., Borgioni C., Ciucci A., Battistelli M., Guerrieri M., Gatteschi C., Zampi I., Santucci A., Ambulatory blood pressure: An independent predictor of prognosis in essential hypertension. Hypertension 1994; 24: 793–801 - PubMed
    1. Staessen JA, Thijs L., Fagard R., O'Brien ET, Clement D., de Leeuw PW, Mancia G., Nachev C., Palatini P., Parati G., Tuomilehto J., Webster J., Predicting cardiovascular risk using conventional vs. ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. J Am Med Assoc 1999; 282: 539–546 - PubMed
    1. Mancia G., Zanchetti A., Agabiti‐Rosei E., Benemio G., De Cesaris R, Fogari R., Pessina A., Porcellati C., Rappelli A., Salvetti A., Trimarco B., Agebiti‐Rosei E., Pessino A., Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment‐induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation. Circulation 1997; 95: 1464–1470 - PubMed
    1. White WB, Analysis of ambulatory blood pressure data in antihypertensive drug trials. J Hypertens 1991: 9 (suppl): S27–32 - PubMed